Related Experiment Video
Updated: Feb 12, 2026

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy
Chinedu O Mmeje1, Cooper R Benson1, Graciela M Nogueras-González2
1Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
The recovery window between neoadjuvant chemotherapy and radical cystectomy for bladder cancer does not impact 90-day postoperative morbidity. However, delaying radical cystectomy beyond 12 weeks increases the risk of lymph node metastasis.
Area of Science:
- Urology
- Oncology
- Surgical Oncology
Background:
- Neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is a standard treatment for muscle-invasive bladder cancer.
- The optimal timing for RC after NAC remains a subject of investigation.
- Understanding the impact of the recovery window (RW) on patient outcomes is crucial for treatment planning.
Purpose of the Study:
- To investigate the association between the recovery window (RW) and 90-day postoperative morbidity after radical cystectomy (RC).
- To determine the effect of the RW on the incidence of lymph node metastasis in bladder cancer patients.
- To identify predictors of perioperative morbidity and lymph node metastasis in patients undergoing NAC and RC.
Main Methods:
- Retrospective review of 306 patients with ≤cT4 N0 M0 bladder cancer treated with NAC and RC between 1995 and 2013.
- Patients were stratified into four RW groups based on 21-day intervals (18-42, 43-63, 64-84, and ≥85 days).
- Generalized linear models were used to analyze the association of RW with 90-day perioperative morbidity and lymph node metastasis.
Main Results:
- No significant differences in overall morbidity, re-admission, or major complication rates were observed across the four RW groups.
- Extravesical disease, older age, and longer surgical duration (≥7 hours) were independent predictors of perioperative morbidity.
- A RW of ≥85 days was associated with the highest incidence of node-positive disease (40%) and was an independent predictor of nodal metastasis (OR 2.92, P=0.018).
Conclusions:
- Patients with bladder cancer can safely undergo radical cystectomy between 18 and 84 days after neoadjuvant chemotherapy without increased perioperative morbidity.
- Delaying radical cystectomy beyond 12 weeks (84 days) following neoadjuvant chemotherapy is associated with a significantly increased risk of lymph node metastasis.
- Optimizing the timing of radical cystectomy after neoadjuvant chemotherapy is essential to balance oncologic outcomes and surgical risks.
More Related Videos
Related Concept Videos
Radical Reactivity: Nucleophilic Radicals
Radicals
Radical Reactivity: Electrophilic Radicals
Radical Autoxidation
Radical Equations
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...

